{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:36:48Z","timestamp":1790393808907,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015755","name":"Biomedical Research Network Center of Hepatic and Digestive Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013941","name":"Biomedical Research Network Centre of Diabetes and Associated Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Government of Catalonia Agency for Administration of University and Research Grants","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.metabol.2026.156710","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:20:13Z","timestamp":1784676013000},"page":"156710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease"],"prefix":"10.1016","volume":"183","author":[{"given":"Aida","family":"Mata-Ventosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marsal-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Medina-Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Ormaz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Balaguer-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Artuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia M.P.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Eduardo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Hern\u00e1ndez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ramos-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00e7al","family":"Pastor-Anglada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Fern\u00e1ndez-Veledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"P\u00e9rez-Torras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.metabol.2026.156710_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2026.156710_bb0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.metabol.2026.156710_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.it.2016.04.004","article-title":"Purinergic signaling during immune cell trafficking","volume":"37","author":"Ferrari","year":"2016","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156710_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00109-013-0999-z","article-title":"Extracellular adenosine signaling in molecular medicine","volume":"91","author":"Eltzschig","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"10.1016\/j.metabol.2026.156710_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11302-020-09715-0","article-title":"Design and in vivo activity of a","volume":"16","author":"Suresh","year":"2020","journal-title":"Purinergic Signal"},{"issue":"6","key":"10.1016\/j.metabol.2026.156710_bb0030","first-page":"2256","article-title":"The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice","volume":"44","author":"Fishman","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.metabol.2026.156710_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00124","article-title":"Historical and current adenosine receptor agonists in preclinical and clinical development","volume":"13","author":"Jacobson","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.metabol.2026.156710_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.718429","article-title":"Purinergic signaling in liver pathophysiology","volume":"12","author":"Jain","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.metabol.2026.156710_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069114","article-title":"Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis","volume":"8","author":"Chiang","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.metabol.2026.156710_bb0050","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.106.112250","article-title":"Effect of a specific and selective a(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma","volume":"320","author":"Mustafa","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.metabol.2026.156710_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.29777","article-title":"Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity","volume":"68","author":"Cai","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2026.156710_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2022.09.027","article-title":"Hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation","volume":"164","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"issue":"4 Pt 1","key":"10.1016\/j.metabol.2026.156710_bb0065","doi-asserted-by":"crossref","first-page":"C799","DOI":"10.1152\/ajpcell.1989.256.4.C799","article-title":"Turnover of adenosine in plasma of human and dog blood","volume":"256","author":"M\u00f6ser","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2026.156710_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cellsig.2017.11.002","article-title":"Enhancement of inosine-mediated a","volume":"42","author":"Welihinda","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2026.156710_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043970","article-title":"Inosine: a bioactive metabolite with multimodal actions in human diseases","volume":"13","author":"Kim","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7926","key":"10.1016\/j.metabol.2026.156710_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41586-022-05041-0","article-title":"Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine","volume":"609","author":"Niemann","year":"2022","journal-title":"Nature"},{"issue":"6330","key":"10.1016\/j.metabol.2026.156710_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf5375","article-title":"An adipo-biliary-uridine axis that regulates energy homeostasis","volume":"355","author":"Deng","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.metabol.2026.156710_bb0090","article-title":"Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases","volume":"15","author":"Yang","year":"2024","journal-title":"Front Physiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0165-6147(99)01298-5","article-title":"Uridine and its nucleotides: biological actions, therapeutic potentials","volume":"20","author":"Connolly","year":"1999","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.metabol.2026.156710_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5152\/tjg.2022.21911","article-title":"Mitochondrial homeostasis and mast cells in experimental hepatic ischemia-reperfusion injury of rats","volume":"33","author":"Koc","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156710_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146994","article-title":"Chronic uridine administration induces fatty liver and pre-diabetic conditions in mice","volume":"11","author":"Urasaki","year":"2016","journal-title":"PloS One"},{"issue":"19\u201320","key":"10.1016\/j.metabol.2026.156710_bb0110","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.cca.2011.06.006","article-title":"Biochemistry of uridine in plasma","volume":"412","author":"Yamamoto","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0115","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","article-title":"An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease","volume":"78","author":"Lee","year":"2023","journal-title":"J Hepatol"},{"issue":"22","key":"10.1016\/j.metabol.2026.156710_bb0120","doi-asserted-by":"crossref","first-page":"21169","DOI":"10.1074\/jbc.M412343200","article-title":"Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene","volume":"280","author":"Cao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156710_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00606","article-title":"Emerging roles of nucleoside transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156710_bb0130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/j.2040-4603.2018.tb00034.x","article-title":"Intestinal nucleoside transporters: function, expression, and regulation","volume":"8","author":"Pastor-Anglada","year":"2018","journal-title":"Compr Physiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0135","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41588-024-01709-7","article-title":"A spatiotemporal atlas of mouse liver homeostasis and regeneration","volume":"56","author":"Xu","year":"2024","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.metabol.2026.156710_bb0140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1124\/dmd.104.001123","article-title":"Tissue distribution of concentrative and equilibrative nucleoside transporters in male and female rats and mice","volume":"32","author":"Lu","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.metabol.2026.156710_bb0145","doi-asserted-by":"crossref","first-page":"G570","DOI":"10.1152\/ajpgi.00542.2007","article-title":"Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes","volume":"295","author":"Govindarajan","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2026.156710_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0155","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2026.156710_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-022-04629-z","article-title":"Hepatocyte PPAR\u03b3 contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice","volume":"80","author":"Lee","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"10.1016\/j.metabol.2026.156710_bb0165","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J Hepatol"},{"issue":"572","key":"10.1016\/j.metabol.2026.156710_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.metabol.2026.156710_bb0175","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","article-title":"RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease","volume":"70","author":"Afonso","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.metabol.2026.156710_bb0180","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/liv.15682","article-title":"miR-21-5p promotes NASH-related hepatocarcinogenesis","volume":"43","author":"Rodrigues","year":"2023","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.metabol.2026.156710_bb0185","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nn1288","article-title":"The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference","volume":"7","author":"Choi","year":"2004","journal-title":"Nat Neurosci"},{"issue":"13","key":"10.1016\/j.metabol.2026.156710_bb0190","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"lumi: a pipeline for processing Illumina microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.metabol.2026.156710_bb0195","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.metabol.2026.156710_bb0200","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/gb-2003-4-10-r70","article-title":"Identifying biological themes within lists of genes with EASE","volume":"4","author":"Hosack","year":"2003","journal-title":"Genome Biol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156710_bb0205","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41436-018-0328-6","article-title":"Laboratory analysis of amino acids, 2018 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"20","author":"Sharer","year":"2018","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0210","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41590-019-0372-7","article-title":"SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity","volume":"20","author":"Keiran","year":"2019","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156710_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1349-7006.2002.tb01250.x","article-title":"Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL\/6J male mice given a choline-deficient, L-amino acid-defined diet","volume":"93","author":"Denda","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"10.1016\/j.metabol.2026.156710_bb0220","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/hep.23100","article-title":"Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL\/6 mice","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12801","article-title":"Type 1 equilibrative nucleoside transporter (ENT1) regulates sex-specific ethanol drinking during disruption of circadian rhythms","volume":"25","author":"Jia","year":"2020","journal-title":"Addict Biol"},{"issue":"17\u201318","key":"10.1016\/j.metabol.2026.156710_bb0230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.lfs.2011.08.007","article-title":"Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge","volume":"89","author":"Rose","year":"2011","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.metabol.2026.156710_bb0235","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166011","article-title":"Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling","volume":"8","author":"Ruan","year":"2023","journal-title":"JCI Insight"},{"issue":"20","key":"10.1016\/j.metabol.2026.156710_bb0240","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121521","article-title":"Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation","volume":"3","author":"Aherne","year":"2018","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.metabol.2026.156710_bb0245","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1096\/fj.13-228551","article-title":"Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury","volume":"27","author":"Eckle","year":"2013","journal-title":"FASEB J"},{"issue":"27","key":"10.1016\/j.metabol.2026.156710_bb0250","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1021\/acs.jafc.1c01781","article-title":"Protective effects of microbiome-derived inosine on lipopolysaccharide-induced acute liver damage and inflammation in mice via mediating the TLR4\/NF-\u03baB pathway","volume":"69","author":"Guo","year":"2021","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.metabol.2026.156710_bb0255","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mam.2017.01.003","article-title":"Molecular implications of adenosine in obesity","volume":"55","author":"Pardo","year":"2017","journal-title":"Mol Aspects Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156710_bb0260","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41575-023-00888-8","article-title":"Hepatic glucose metabolism in the steatotic liver","volume":"21","author":"Scoditti","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.metabol.2026.156710_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/nu16070920","article-title":"Ticagrelor, but not Clopidogrel, attenuates hepatic steatosis in a model of metabolic dysfunction-associated Steatotic liver disease","volume":"16","author":"Lee","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.metabol.2026.156710_bb0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1074248413511693","article-title":"Characterization of the adenosine pharmacology of ticagrelor reveals therapeutically relevant inhibition of equilibrative nucleoside transporter 1","volume":"19","author":"Armstrong","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.metabol.2026.156710_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118848","article-title":"ENT1 inhibition enhances weight control and metabolic health in diet-induced obesity","volume":"193","author":"Chaible","year":"2025","journal-title":"Biomed Pharmacother"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:02:26Z","timestamp":1787155346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"alternative-id":["S0026049526002234"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156710","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Equilibrative nucleoside transporter 1 deficiency protects against diet-induced MASLD and is stage-associated in human liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156710"}}